Descrição

Cytotoxicity or biocompatibility assessment of the betamethasone-minoxidil nanoparticles on skin cell cultures. Cell viability data confirm the safety profile of the topical nanoformulations for alopecia treatment.

Figure 12

Chart

Source Paper

Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polymeric and Lipid Nanoparticles for Topical Alopecia Areata Treatment.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37765130

DOI: 10.3390/ph16091322

Cite This Figure

![Figure 12: Cytotoxicity or biocompatibility assessment of the betamethasone-minoxidil nanoparticles on skin cell cultures. Cell viability data confirm the safety profile of the topical nanoformulations for alopecia treatment.]()

> Source: Breno N Matos et al. "Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polyme." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37765130](https://pubmed.ncbi.nlm.nih.gov/37765130/)

<figure>
  <img src="" alt="Cytotoxicity or biocompatibility assessment of the betamethasone-minoxidil nanoparticles on skin cell cultures. Cell viability data confirm the safety profile of the topical nanoformulations for alopecia treatment." />
  <figcaption>Figure 12. Cytotoxicity or biocompatibility assessment of the betamethasone-minoxidil nanoparticles on skin cell cultures. Cell viability data confirm the safety profile of the topical nanoformulations for alopecia treatment.<br>  Source: Breno N Matos et al. "Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polyme." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37765130/">37765130</a></figcaption>
</figure>

Evidências Relacionadas

Minoxidil para Alopecia Areata

Nota A · 122 estudos